PFASs	Per- and polyfluoroalkyl substances
ICU	Intensive care units
PTFE	Polytetrafluoroethylene
PVDF	Polyvinylidene fluoride
IVD	In vitro diagnostic
HFP	Hexafluoro-2-propanol
TFA	Trifluoroacetic acid
FEP	Fluorinated ethylene propylene
PCTFE	Poly(chlorotrifluoroethylene)
ETFE	Ethylene tetrafluoroethylene
FKM/FPM	Fluoroelastomers
FFKM/FFPM	Perfluoroelastomers
PVDF	Polyvinylidene fluoride
PVDF-HFP	Poly(vinylidene fluoride-hexafluoropropylene)
C6–C14	Perfluorinated acrylates
AFFFs	Aqueous film-forming foams
MAFLD	Metabolic-associated fatty liver disease
NAFLD	Non-alcoholic fatty liver disease
EU	European Union
ECHA	European Chemicals Agency
REACH	Registration, Evaluation, Authorisation, and Restriction of Chemicals
EPA	Environmental Protection Agency
CERCLA	Comprehensive Environmental Response, Compensation, and Liability Act
MCLs	Maximum contaminant levels
WHO	World Health Organization
PPAR	Peroxisome proliferator-activated receptor
PFOS	Perfluorooctane sulfonate
PFOA	Perfluoroalkyl and polyfluoroalkyl substances
TSCA	Toxic Substances Control Act
MDR	Medical device regulation
MDD	Medical device directive
NIS	Na+/I- symporter
EtFOSAA	N-ethyl perfluorooctane sulfonamido acetic acid
PPAR-α	Peroxisome proliferator-activated receptor alpha
ASD	Autism spectrum disorder
ADHD	Attention-deficit/hyperactivity disorder
SHBG	Sex hormone binding globulin
OWO	Obesity and overweight
PBPK	Physiologically based pharmacokinetic
MAFLD	Metabolic-associated fatty liver disease
NAFLD	Non-alcoholic fatty liver disease
AAC	Aortic calcification
AFFF	Aqueous film-forming foams
MeSH	Medical subject headings